Roper Martin 4

What Happened
Roper Martin, CEO of Vita Coco (COCO), exercised 50,000 stock options across April 14–15, 2026 and promptly sold those 50,000 shares in the open market. On 2026-04-14 he exercised 25,000 shares at $10.18 (reported cost $254,450) and sold 25,000 shares at a weighted avg $50.00 (proceeds $1,250,000). On 2026-04-15 he repeated the same: exercised 25,000 at $10.18 ($254,450) and sold 25,000 at $50.11 (proceeds $1,252,675). Total sale proceeds were $2,502,675 against exercise costs of $508,900, yielding roughly $1.99M in net proceeds. The filing also shows derivative disposition line items at $0 related to the option conversion.

Key Details

• Dates: Exercises and sales occurred 2026-04-14 and 2026-04-15; Form 4 filed 2026-04-16 (timely).
• Exercise: 50,000 shares exercised total (25,000 each day) at $10.18 (total reported cost $508,900).
• Sales: 50,000 shares sold total (25,000 each day) for total proceeds $2,502,675; weighted prices reported and sales ranged $50.00–$50.30.
• 10b5-1 plan: Sales were effected pursuant to a Rule 10b5-1 trading plan (pre‑arranged trades).
• Price detail: The April 14 sale weighted avg $50.00 (range shown up to $50.30); April 15 sale weighted avg $50.11. The filer offers to provide per‑trade prices on request.
• Shares owned after transaction: Not specified in this Form 4.
• Derivative lines at $0 reflect option conversion/exercise (not a separate paid sale).

Context
This was an exercise followed by an immediate market sale (commonly a cashless exercise or sell-to-cover), executed under a pre‑arranged 10b5-1 plan — a routine liquidity event for insiders rather than an unsolicited market-timing trade. Because the sales were pre‑planned, they may be less informative about the CEO’s short‑term view of the stock. The filing was reported on time.